External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials
Angie Mae Rodday(Tufts Medical Center), Susan K. Parsons(Tufts Medical Center), David Hodgson(The University of Texas MD Anderson Cancer Center), John Radford(Manchester Academic Health Science Centre), Kerry J. Savage(Spinal Cord Injury BC), Nicholas Counsell(University College London), Dennis A. Eichenauer(University of Cologne), Eric Mou(Stanford University), Matthew J. Maurer(Mayo Clinic in Arizona), Ranjana H. Advani(Stanford Medicine), Hocine Tighiouart(Tufts University), Annette E. Hay(Queen's University), Andrew M. Evens(Rutgers, The State University of New Jersey), Peter Borchmann(University of Cologne), Martin Hutchings(University of Copenhagen), Sven Borchmann(University of Cologne), James R. Cerhan(Mayo Clinic), Richard T. Hoppe(Stanford Medicine), Sára Rossetti(Copenhagen University Hospital), Jenica Upshaw(Beth Israel Deaconess Medical Center), Brian K. Link(University of Iowa), Cui Zhu(Tufts Medical Center), Massimo Federico(University of Modena and Reggio Emilia), Janina Jablonski(University Hospital Cologne), Marc André(CHU Dinant Godinne UCL Namur), Peter Johnson(Cancer Research UK)
Cited by 1
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
|New England Journal of Medicine|2012|4.1k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k